Introduction
Coronary artery aneurysm (CAA) is an infrequent finding in routine coronary angiography (CAG), thereby presenting as a therapeutic quandary for most treating doctors. Though most of the CAAs are asymptomatic, they may present with various clinical presentations like angina pectoris, fistula formation, pericardial tamponade, compression of surrounding structures, congestive heart failure or sudden death.
Here, we discuss a case of iatrogenic CAA following percutaneous transluminal coronary angioplasty (PTCA) with its relevant management strategy.
Case Report
A 65-year-old, hypertensive female presented with acute inferior wall myocardial infarction with complete heart block at another centre (Fig. 1a) . Reperfusion therapy was given in the form of thrombolysis with streptokinase. CAG revealed 90% stenoses of the left anterior descending (LAD) artery and 1st diagonal branch and proximal occlusion of the right coronary artery (RCA). PTCA to the infarct-related vessel (RCA) using a drug-eluting stent (DES) was performed.
After 3 months, she presented to our centre with a recurrence of the symptoms and was diagnosed with inferior non-ST-elevation myocardial infarction with moderate LV dysfunction (ejection fraction, 38%) (Fig. 1b) .
Repeat CAG revealed an incidental finding of a large fusiform CAA of the RCA at the site of stent implantation ( Fig. 2a-d) .
She opted for the surgical management under cardiopulmonary bypass via median sternotomy. Initially, the proximal and distal communications of RCA were ligated from within the aneurysmal sac and then coronary artery bypass grafting was done using the left internal mammary artery graft to the LAD and saphenous vein grafts to the RCA and 1st diagonal was performed ( Fig. 3a-b) .
The patient was discharged on the 7th postoperative day with medical treatment in the form of dual antiplatelet agents, metoprolol, ramipril and statin. She is asymptomatic at the 8-month follow-up.
Discussion
Though atherosclerosis is the most common cause of CAA, there are increasing case reports implying DES causing iatrogenic CAA at variable duration after the procedure with the reported incidence as 3.5 to 5% after PTCA [1] .
Multi-factorial pathogenesis has been proposed for CAA secondary to DES implantation: (1) antiinflammatory and anti-proliferative properties of the drug, (2) the polymer eliciting a hypersensitivity reaction and vasculitis and (3) mechanical damage to the vessel wall during PTCA (coronary dissection). All these pathophysiological factors lead to the weakening of a vessel wall and subsequent dilatation of the vessel wall secondary to turbulent flow and formation of eddy currents [2] .
Large CAA following PTCA is not common within a span of 3 months.
Aoki et al. [3] reviewed multiple case reports of iatrogenic CAA and their treatment strategies, and they proposed medical management using anti-thrombotic therapy for asymptomatic patients and either percutaneous or surgical approach for symptomatic patients depending upon the aetiology, the severity of coronary artery disease and the size of the CAA.
The percutaneous approach is preferred for CAA proximal to stenosis where there is high turbulence and risk of thrombus formation or rupture is high. PTCA using polytetrafluoroethylene coated stents achieves complete or partial sealing of CAAs from the lumen [3] .
The goal of the surgical approach is a restoration of blood flow with the reduction of risk of rupture and prevention of thrombo-embolism to the distal circulation. Complications of resection include disruption of flow to branching vessels and myocardial ischemia. All large CAAs should be marsupialized and inspected for the branching vessels [4] .
If significant branching vessels are found, an interposition graft may use to perfuse these branches. If no branching vessels are present, proximal or distallisation with coronary artery bypass grafting (CABG) is appropriate. Though aneurysmal ligation and CABG are the most common techniques used, Aboud et al. [5] proposed a reconstruction of the coronary artery following the clipping of the aneurysmal segment.
Conclusion
Iatrogenic CAA remains an enigma, seen on CAG, posing a unique therapeutic dilemma. The appropriate management approach is a trade-off between risk versus benefit of each modality on a case to case basis with the end goal of minimising complications related to the disease as well as therapy.
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